SEC Form 3 · accession 0001235802-18-000170
DiaMedica Therapeutics Inc. · DMAC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Period of report
Dec 6, 2018
Accepted (ET)
Dec 6, 2018 · 6:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401040
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Voting Common Shares, no par value per shareF1 | holding | — | — | — | 1,000,000 | I | See Footnote | |
| Voting Common Shares, no par value per shareF2 | holding | — | — | — | 3,850 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4,F3 | $4.82 | holding | — | — | — | — | Jun 19, 2027 | Voting Common Shares | 5,000 | — | D |
| Stock Option (right to buy)F4,F5 | $8.43 | holding | — | — | — | — | Apr 17, 2028 | Voting Common Shares | 3,000 | — | D |
Explanation of responses
- F1These voting common shares are held by Hermeda Industrial Co., Limited, Zhenyu Xiao, Ph.D. is the Director of Hermeda Industrial Co., Limited and has sole voting and dispositive power over the voting common shares held by Hermeda Industrial Co., Limited.
- F2These voting common shares are issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- F3This stock option vests in 12 equal quarterly installments over three years starting on September 19, 2017.
- F4Represents the conversion of the exercise price from CAD$ to US$ on November 30, 2018.
- F5This stock option vests in 12 equal quarterly installments over three years starting on July 17, 2018.